Mutations in the mevalonate pathway genes in Chinese patients with porokeratosis
Mutations in the mevalonate pathway genes in Chinese patients with porokeratosis
复制标题
中国汗孔角化症患者甲羟戊酸途径基因突变
DOI:
10.1111/jdv.13653
复制
发表时间:
2016-09-01
影响因子:
9.2
通讯作者:
Yao, Z.
中科院分区:
文献类型:
--
作者:
Li, M.;Li, Z.;Yao, Z.
BackgroundPorokeratosis (PK, MIM 175800) is a chronic autosomal dominant cutaneous keratinization disorder, which has a wide variety of clinical manifestations.ObjectivesWe analysed the molecular basis of 10 families and 12 sporadic cases with different subtypes of porokeratosis in the Chinese population.MethodsGenomic DNA was extracted from peripheral blood samples. Mutation screening was performed by direct sequencing of exons and flanking intron-exon boundaries for the entire coding region of four mevalonate pathway genes and SLC17A9 gene.ResultsWe detected three novel mutations and seven previously described mutations by direct sequence analysis of the PCR products. Mutations p.Phe249Ser and p.Asn292Ser in mevalonate decarboxylase (MVD) were the most common mutations in this PK cohort; their presence was 27.3% and 13.6% respectively.ConclusionsThis study extended the mutation spectrum of PK in the Chinese Han population and provided further evidence for the genetic basis of PK. We first identified MVD simultaneously responsible for porokeratosis palmaris et plantaris disseminate development and confirmed the genotype-phenotype correlations.